CNR1 and lung carcinoma: Since several studies described CB receptor expression in tumors of NSCLC patients (2, 3, 7), we stained sections of human lung cancer tissues to assess the distribution of CB1 and CB2 receptors in tumor cells and infiltrating immune cells, and also applied flow cytometry in freshly resected NSCLC tissues.